I 
119TH CONGRESS 
1ST SESSION H. R. 6130 
To amend title XVIII of the Social Security Act to provide for Medicare 
coverage of blood-based dementia screening tests. 
IN THE HOUSE OF REPRESENTATIVES 
NOVEMBER 19, 2025 
Mr. BUCHANAN (for himself and Mr. TONKO) introduced the following bill; 
which was referred to the Committee on Energy and Commerce, and in 
addition to the Committee on Ways and Means, for a period to be subse-
quently determined by the Speaker, in each case for consideration of such 
provisions as fall within the jurisdiction of the committee concerned 
A BILL 
To amend title XVIII of the Social Security Act to provide 
for Medicare coverage of blood-based dementia screening 
tests. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Alzheimer’s Screening 
and Prevention Act of 2025’’ or the ‘‘ASAP Act’’. 
VerDate Sep 11 2014 
02:57 Nov 25, 2025
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6130.IH
H6130
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SEC. 2. MEDICARE COVERAGE OF ALZHEIMER’S DISEASE 
AND RELATED DEMENTIAS EARLY DETEC-
TION SCREENING TESTS. 
(a) COVERAGE.—Section 1861 of the Social Security 
Act (42 U.S.C. 1395x) is amended— 
(1) in subsection (s)(2)— 
(A) in subparagraph (JJ), by striking the 
semicolon at the end and inserting ‘‘; and’’; and 
(B) by adding at the end the following new 
subparagraph: 
‘‘(KK) Alzheimer’s disease and related demen-
tias early detection screening tests (as defined in 
subsection (nnn));’’; and 
(2) by adding at the end the following new sub-
section: 
‘‘(nnn) ALZHEIMER’S DISEASE AND RELATED DE-
MENTIAS EARLY DETECTION SCREENING TESTS.—The 
term ‘Alzheimer’s disease and related dementias early de-
tection screening test’ means a test furnished to an indi-
vidual for the detection of the pre-symptomatic and early 
stage of Alzheimer’s disease or related dementias on or 
after January 1, 2028, that— 
‘‘(1) is cleared under section 510(k), classified 
under section 513(f)(2), or approved under section 
515 of the Federal Food, Drug, and Cosmetic Act; 
and 
VerDate Sep 11 2014 
02:57 Nov 25, 2025
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6130.IH
H6130
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(2) is— 
‘‘(A) a genomic sequencing blood or blood 
product test; or 
‘‘(B) such other equivalent test, including 
a single-analyte test, blood test analysis of cell- 
free nucleic acids, multiplex panel test, whole 
genome sequencing, protein expression, whole 
exome, whole transcriptome, and medical imag-
ing (which are based on blood, blood products, 
tissue, urine or other biospecimen), as the Sec-
retary determines appropriate in providing re-
sults comparable to those obtained with a test 
described in subparagraph (A).’’. 
(b) PAYMENT.—Section 1833(h)(1)(A) of the Social 
Security Act (42 U.S.C. 1395l(h)(1)(A)) is amended by 
inserting ‘‘Alzheimer’s disease and related dementias early 
detection screening tests under section 1861(nnn) and’’ 
after ‘‘including’’. 
Æ 
VerDate Sep 11 2014 
02:57 Nov 25, 2025
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H6130.IH
H6130
kjohnson on DSK7ZCZBW3PROD with $$_JOB